Utilizing Preclinical Models to Predict Efficacy of Regenerative Stem Cell Therapies
Time: 3:45 pm
day: Conference Day One
Details:
- Developing preclinical stem cell models to validate efficacy and safety to accelerate IND approvals
- Bridging in vitro and large animal data for human-relevant insights to improve clinical translation
- Leveraging biomarker strategies through academics and CRO partnerships to de-risk therapy development
